July 12, 2016
(Reuters) – The biggest barrier to high-quality end-of-life care for patients with blood cancers may be unrealistic expectations, a new survey found. For patients with solid-tumor cancers, standards for quality end-of-life care include not receiving chemotherapy in the last two weeks before death, and not being intubated in the final month. Doctors caring for patients with blood cancers like lymphoma or leukemia believe the same standards can apply to them, too.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.